Medco Health Solutions, Inc. (NYSE:MHS)
| CAPS Rating |
|
|---|---|
| Open | $60.00 |
| Previous Close | $60.49 |
| Daily Range | $59.28 - $60.88 |
| 52-Week Range | $44.60 - $66.38 |
| Market Cap | $23.45B |
| P/E Ratio | 14.70 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 7,398,520 |
| Average Daily Volume | 0 |
MHS
VS S&P 500 (SPY)
How do you think MHS will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MHS Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MHS News and Commentary
- CVS Reports Mixed Results - Analyst Blog – NASDAQ
- Insurer Coventry Health Care Extends Pact With Medco By 3 Years – SmartMoney
- Zacks' Voice of the People highlights opportunities with The SPDR S&P 500 Index, Express Scripts and – NASDAQ
- Why the Market Should Close After the Super Bowl - Voice of the People – NASDAQ
- Medco Health Solutions and Express Scripts Shares Dipped: What You Need to Know – The Motley Fool
- Big Grocery Chains Ask FTC To Block Medco-Express Scripts Deal -Reuters – SmartMoney
- February's Flurry Of Issuance Continues For High-Grade Corporates – SmartMoney
- UPDATE: Lazard Swings To 4Q Loss On Slump In Advisory Revenue – SmartMoney
- Walgreen Loses if It Can't Make Up With Express Scripts – Minyanville
- Two Companies That Should Pay A Dividend – Blogs @ The Motley Fool
- Fed official owned shares of bailed out firms – CNN Money
- UPDATE: Express Scripts' Lipitor Move Highlights Pressure On Pfizer – SmartMoney
- Benefit Manager's Lipitor Move Highlights Pressure On Pfizer – SmartMoney
- 2nd UPDATE: UnitedHealth 4Q Profit Up 21% As Membership Grows – SmartMoney
- 2 Medical Stocks to Buy, 3 to Avoid in 2012 – Blogs @ The Motley Fool
- FTC Orders CVS to Settle Claims - Analyst Blog – NASDAQ
- 3rd UPDATE: FTC: CVS Caremark Settles Deceptive-Pricing Charges, Will Pay $5 Million – SmartMoney
- 2nd UPDATE: FTC: CVS Caremark Settles Deceptive-Pricing Charges, Will Pay $5 Million – SmartMoney
- FTC: CVS Caremark Settles Deceptive Pricing Charges, Will Pay $5 Million – SmartMoney
- Drugstore wars ... on Twitter! – CNN Money
RSS Headlines
Fool UK
